表 2.
两组SLE患者的临床特点和实验室指标
Clinical and laboratory characteristics of the two SLE groups
| Items | SLE retinopathy, n=32 | SLE without retinopathy, n=50 | P value |
| SLEDAI, systemic lupus erythematosus disease activity index; Tmax, the highest temperature of the patients who had a fever during the disease; anti-dsDNA, anti-double-stranded DNA antibody; ANA, antinuclear antibody; anti-Sm, anti-Smith antibody; anti-U1 RNP, anti-U1 ribonucleoprotein antibody; anti-SSA, anti-Sjögren syndrome A antibody; anti-SSB, anti-Sjögren syndrome B antibody. # P < 0.01. | |||
| SLEDAI-2000, x±s | 17.41±4.25 | 9.48±5.35 | < 0.001# |
| Clinical Features | |||
| Fever, n (%) | 22 (68.75) | 35 (70.00) | 0.905 |
| Tmax/℃, x±s | 38.92±0.76 | 38.93±0.76 | 0.980 |
| Rash, n (%) | 13 (40.62) | 23 (46.00) | 0.632 |
| Malar erythema, n (%) | 15 (46.88) | 20 (40.00) | 0.539 |
| Arthralgia, n (%) | 20 (62.50) | 32 (64.00) | 0.891 |
| Hair loss, n (%) | 17 (53.12) | 18 (36.00) | 0.126 |
| Mucosal ulcer, n (%) | 11 (34.38) | 10 (20.00) | 0.146 |
| Photosensitivity, n (%) | 5 (15.62) | 9 (18.00) | 0.780 |
| Raynaud’s phenomenon, n (%) | 5 (15.62) | 11 (22.00) | 0.477 |
| Urine occult blood, n (%) | 13 (40.62) | 11 (22.00) | 0.071 |
| Urine protein, n (%) | 19 (59.38) | 25 (50.00) | 0.406 |
| Pleurisy, n (%) | 13 (40.62) | 11 (22.00) | 0.071 |
| Pericarditis, n (%) | 9 (28.12) | 10 (20.00) | 0.395 |
| Antibodies | |||
| anti-dsDNA (+), n (%) | 12 (37.50) | 21 (42.00) | 0.770 |
| ANA (+), n (%) | 28 (87.50) | 48 (96.00) | 0.314 |
| anti-Sm (+), n (%) | 3 (9.38) | 12 (24.00) | 0.095 |
| anti-U1 RNP (+), n (%) | 10 (31.25) | 19 (38.00) | 0.533 |
| anti-SSA (+), n (%) | 12 (37.50) | 26 (52.00) | 0.199 |
| anti-SSB (+), n (%) | 2 (6.25) | 4 (8.00) | >0.999 |